Topically applied tacrolimus ointment in pediatric atopic dermatitis patients: Results of a large open-label study

被引:2
|
作者
Schneider, L
Roberts, R
Berger, W
Prenner, BM
机构
[1] Harvard Univ, Childrens Hosp, Sch Med, Boston, MA 02115 USA
[2] Univ Calif Los Angeles, Los Angeles, CA USA
[3] So Calif Res, Mission Viejo, CA USA
[4] Allergy Associates Med Grp Inc, San Diego, CA USA
关键词
D O I
10.1016/S0091-6749(02)81606-2
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
470
引用
收藏
页码:S160 / S160
页数:1
相关论文
共 50 条
  • [31] Delgocitinib ointment in pediatric patients with atopic dermatitis: A phase 3, randomized, double-blind, vehicle-controlled study and an open-label, long-term extension study
    Nakagawa, Hidemi
    Nemoto, Osamu
    Igarashi, Atsuyuki
    Saeki, Hidehisa
    Kabashima, Kenji
    Oda, Manabu
    Nagata, Takeshi
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB52 - AB52
  • [32] Open-label trial of dupilumab for adolescents with atopic dermatitis
    Ingram, John
    BRITISH JOURNAL OF DERMATOLOGY, 2020, 182 (01) : IX - IX
  • [33] An Open-Label Prospective Study to Compare the Efficacy and Safety of Topical Fluticasone Versus Tacrolimus in the Proactive Treatment of Atopic Dermatitis
    Mudaliyar, Vinodhini R.
    Pathak, Asha
    Dixit, Alok
    Kumar, Sweta S.
    DERMATOLOGY PRACTICAL & CONCEPTUAL, 2020, 10 (04):
  • [34] Dupilumab facial dermatitis in atopic dermatitis patients ameliorated by topical crisaborole: An open-label case series study
    Lin, Han-Wen
    Chung, Wen-Hung
    Chen, Chun-Bing
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2025, 39 (02) : e181 - e183
  • [35] Safety and Tolerability of a Body Wash and Moisturizer When Applied to Infants and Toddlers with a History of Atopic Dermatitis: Results from an Open-Label Study
    Simpson, Eric
    Trookman, Nathan S.
    Rizer, Ronald L.
    Preston, Norman
    Colon, Luz E.
    Johnson, Lori A.
    Gottschalk, Ronald W.
    PEDIATRIC DERMATOLOGY, 2012, 29 (05) : 590 - 597
  • [36] Pancreatic Enzyme Supplementation in Patients with Atopic Dermatitis and Food Allergies: An Open-Label Pilot Study
    Sanford Singer
    Jamie Koenekoop
    Jonathan Meddings
    Julie Powell
    Anne Desroches
    Ernest G. Seidman
    Pediatric Drugs, 2019, 21 : 41 - 45
  • [37] An Open-Label Prospective Observational Study of Tralokinumab in Atopic Dermatitis Patients with Inadequate Response to Dupilumab
    Polaskey, Meredith Tyree
    Fakhraie, Sheiva
    Daftary, Karishma
    Chovatiya, Raj
    DERMATITIS, 2024,
  • [38] Pancreatic Enzyme Supplementation in Patients with Atopic Dermatitis and Food Allergies: An Open-Label Pilot Study
    Singer, Sanford
    Koenekoop, Jamie
    Meddings, Jonathan
    Powell, Julie
    Desroches, Anne
    Seidman, Ernest G.
    PEDIATRIC DRUGS, 2019, 21 (01) : 41 - 45
  • [39] Safety, efficacy, and pharmacokinetics of delgocitinib ointment in infants with atopic dermatitis: A phase 3, open-label, and long-term study
    Nakagawa, Hidemi
    Igarashi, Atsuyuki
    Saeki, Hidehisa
    Kabashima, Kenji
    Tamaki, Tomomi
    Kaino, Hironobu
    Miwa, Yasushi
    ALLERGOLOGY INTERNATIONAL, 2024, 73 (01) : 137 - 142
  • [40] Tacrolimus ointment versus pimecrolimus cream in patients with moderate atopic dermatitis
    Breneman, D
    Fleischer, AB
    Antaya, R
    Langley, RG
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2005, 52 (03) : P73 - P73